JAMI MANNLE: Open Payments
NPI 1184857674 · O FALLON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 53 payments from 10 companies in 2025. Trend: 2023 $1,323 · 2024 $1,596 · 2025 $964
Food & beverage: $889Education: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $457 |
| Janssen Biotech, Inc. | 4 | $145 |
| Amgen Inc. | 5 | $98 |
| Incyte Corporation | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Lilly USA, LLC | 2 | $41 |
| Organon LLC | 6 | $33 |
| UCB, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
Products named: SKYRIZI, TREMFYA, RINVOQ, OTEZLA, OPZELURA, TALTZ, VTAMA, Bimzelx.
Industry payments across IL — which companies pay providers there.
